User profiles for B.R. Graham
Brett R GrahamAssistant Professor, University of Saskatchewan Verified email at usask.ca Cited by 1017 |
Canadian stroke best practice recommendations: secondary prevention of stroke update 2020
The 2020 update of the Canadian Stroke Best Practice Recommendations (CSBPR) for the
Secondary Prevention of Stroke includes current evidence-based recommendations and …
Secondary Prevention of Stroke includes current evidence-based recommendations and …
Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised …
…, B Beauchamp, B Mahlitz, BR Graham… - The Lancet, 2022 - thelancet.com
Background Intravenous thrombolysis with alteplase bolus followed by infusion is a global
standard of care for patients with acute ischaemic stroke. We aimed to determine whether …
standard of care for patients with acute ischaemic stroke. We aimed to determine whether …
Paleostress in cratonic North America: Implications for deformation of continental interiors
BA Van der Pluijm, JP Craddock, BR Graham… - Science, 1997 - science.org
Compressive paleostresses, as recorded by twinned calcite in carbonate rocks that cover
cratonic northwestern North America, are perpendicular to the orogenic front of the Late …
cratonic northwestern North America, are perpendicular to the orogenic front of the Late …
Beta-adrenergic blocking drugs in the treatment of hypertension
BNC Prichard, JM Cruickshank, BR Graham - Blood Pressure, 2001 - Taylor & Francis
The reduction in blood pressure seen with the use of beta-blocking drugs was an unexpected
finding. Initially there was resistance to their use as the reduction of cardiac output and …
finding. Initially there was resistance to their use as the reduction of cardiac output and …
Hashimoto encephalopathy presenting with stroke-like episodes in an adolescent female: a case report and literature review
Background Hashimoto encephalopathy is a rare form of encephalopathy thought to be of
autoimmune etiology. Cognitive changes and seizures are the most commonly reported …
autoimmune etiology. Cognitive changes and seizures are the most commonly reported …
Time for a time window extension: insights from late presenters in the ESCAPE trial
JW Evans, BR Graham, P Pordeli… - American Journal …, 2018 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: The safety and efficacy of endovascular therapy for large-artery
stroke in the extended time window is not yet well-established. We performed a …
stroke in the extended time window is not yet well-established. We performed a …
Characterization of Metarhizium anisopliae strains by carbohydrate utilization (API50CH)
AC Rath, CJ Carr, BR Graham - Journal of Invertebrate Pathology, 1995 - Elsevier
The utilization of 49 carbohydrates was examined for 134 isolates of Metarhizium anisopliae
covering 16 characterized strains, seven isolates of Metarhizium flavoviride var. flavoviride, …
covering 16 characterized strains, seven isolates of Metarhizium flavoviride var. flavoviride, …
Posterior reversible encephalopathy syndrome in an adult patient undergoing peritoneal dialysis: a case report and literature review
BR Graham, GB Pylypchuk - BMC nephrology, 2014 - Springer
Background Posterior reversible encephalopathy syndrome (PRES) is a clinical and
radiological entity characterized clinically by headache, altered mental status, seizures, visual …
radiological entity characterized clinically by headache, altered mental status, seizures, visual …
Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.
…, CWI Owens, BR Graham - Journal of human …, 1997 - search.ebscohost.com
Moxonidine is a centrally acting antihypertensive. Its action is mediated by imidazoline I 1
receptors located in the rostral ventro-lateral medulla (RVLM). Animal experiments show much …
receptors located in the rostral ventro-lateral medulla (RVLM). Animal experiments show much …
The use of moxonidine in the treatment of hypertension
BNC Prichard, BR Graham - Journal of Hypertension, 1997 - journals.lww.com
Background Imidazoline I 1-receptor agonism represents a new mode of antihypertensive
action to inhibit peripheral α-adrenergic tone by a central mechanism. Adrenaline, …
action to inhibit peripheral α-adrenergic tone by a central mechanism. Adrenaline, …